X4 Pharmaceuticals, Inc. (XFOR) Financials

XFOR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 270.3 million 101.8 million
Dec. 31, 2025 290.5 million 104.2 million
Sept. 30, 2025 163.6 million 101.9 million
June 30, 2025 105.2 million 101.2 million

XFOR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -19.6 million 2.4 million
Dec. 31, 2025 -15.5 million 2.3 million
Sept. 30, 2025 -27.8 million 760000
June 30, 2025 -29.9 million 748000

XFOR Net Income

No data available :(

XFOR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 233.7 million - -
Dec. 31, 2025 253.0 million 76.3 million 994000
Sept. 30, 2025 122.2 million 76.1 million 1.3 million
June 30, 2025 63.0 million 75.8 million 2.2 million

XFOR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 126.3 million
Dec. 31, 2025 110.6 million
Sept. 30, 2025 43.3 million
June 30, 2025 7.4 million

XFOR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 19.6 million 15.5 million 7.0 million -
Dec. 31, 2025 3.0 million 18.5 million 7.4 million -
Sept. 30, 2025 3.0 million 17.3 million 11.6 million -
June 30, 2025 - 18.2 million 9.5 million -

XFOR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 2.7 million 598000
Dec. 31, 2025 2.6 million 387000
Sept. 30, 2025 1.8 million 374000
June 30, 2025 2.0 million 494000

XFOR Revenue by Segment
Graph available only for paid members. Upgrade to see it.

XFOR

Price: $4.04

52 week price:
1.35
4.83

Earnings Per Share: -2.07 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 471700

Market Capitalization: 361.2 million

Links: